Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Induced pacemaker and Purkinje cells from adult stem cells

a technology of stem cells and induced pacemakers, which is applied in the direction of genetically modified cells, skeletal/connective tissue cells, drug compositions, etc., can solve the problems of mechanical and/or electrical failure, irregular beating, and not a perfect solution, so as to eliminate the rejection problem, convenient to use, and convenient to use

Active Publication Date: 2018-03-13
ALLIANCE OF CARDIOVASCULAR RESERS +1
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a study that found a gene called TBX18 is necessary to create the structure of the heart's main pacemakers in mice. The researchers also found that TBX3 can help regulate the expression of genes necessary for pacemakers to function. This information may be useful for improving the quality of stem cells that can be used for regenerative medicine. The text also suggests that allogeneic cells, which are cells from different individuals, could be used for transplantation without requiring immunomodulatory drugs. Additionally, the text mentions that there are millions of different HLA patterns in banks of cord blood and tissue stem cells that could be used for transplantation if there is a match. Lastly, the text suggests that libraries of induced pacemakers or Purkinje cells could be created in advance for use in emergency situations.

Problems solved by technology

Many things can go wrong with the heart resulting in irregular beating.
Although artificial pacemakers have saved many lives, they are not a perfect solution.
In particular, they are not hormone responsive, are subject to mechanical and / or electrical failure, need battery replacement and can be disrupted in strong magnetic fields or in therapeutic radiation settings.
Further, infection is always a hazard, as is pacemaker-mediated tachycardia, suboptimal atrioventricular (AV) synchrony, and several other types of pacemaker induced dysrhythmias.
In this regard, the early key transcription factor TBX3 provided promising results, but led to cells with incomplete pacemaker characteristics.
Despite several attempts in the past to generate cardiac pacemaker cells, there are up to now no correctly functional biological pacemaker cells available for clinical application derived from undifferentiated adult autologous stem cells.
Attempts to generate pacemaker cells in the past failed to mimic the appropriate physiological functionality and morphological properties of natural cardiac pacemaker cells.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Induced pacemaker and Purkinje cells from adult stem cells
  • Induced pacemaker and Purkinje cells from adult stem cells
  • Induced pacemaker and Purkinje cells from adult stem cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0094]The invention provides novel methods of making pacemaker cells and Purkinje cells or sinoatrial nodes (SANs); the pacemaker cells, Purkinje cells, and SANs made thereby; and methods of using same, e.g., to replace or supplement damaged pacemakers and Purkinje fibers in the heart of patients, such as human patients. The cells can be surgically delivered directly or by catheter based injection to the place where they are required. For the repair of the sinus node for example, a catheter based injection of a few thousand cells into the damaged and reduced functioning sinus node is sufficient to effect repair.

[0095]For the repair of tachycardic arrhythmias, Purkinje cell are injected into the slow conducting zone, such as the border zone of an infarction, in order to accelerate the speed of conduction in this arrhythmogenic substrate and thereby to close the re-entry pathway by accelerating the circulating impulse in such a way that it meets refractory myocardium and the re-entry ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
voltagesaaaaaaaaaa
diameteraaaaaaaaaa
cell sizeaaaaaaaaaa
Login to View More

Abstract

Adult stem cells are reprogrammed to form pacemaker cells and Purkinje cells through the sequential activation of SHOX2>TBX5>HCN2. These Purkinje cells spontaneously surround and connect with the larger pacemaker cells, thus forming an induced sinoatrial body that produces funny current and can make cardiovascular tissues beat in a manner similar to a natural sinoatrial node.

Description

PRIOR RELATED APPLICATIONS[0001]Not applicable.FIELD OF THE DISCLOSURE[0002]This invention relates to methods for the generation of non contractile, electrically active induced cardiomyocyte cells for use in treatment of arrhythmias, as well as the induced creation and formation of cells for enhanced electrical activity of the heart such as sinus or sinoatrial node cells and Purkinje cells of the heart thereby produced and used for same.BACKGROUND OF THE DISCLOSURE[0003]The heart (FIG. 1A) is the muscular organ that pumps blood through the blood vessels of the circulatory system. In a healthy mammalian heart, composed of right and left atrium and right and left ventricles, blood flows only one way through the heart because the heart valves prevent backflow. The heart is enclosed in a protective sac, the pericardium, which also contains a small amount of fluid. The wall of the heart is made up of three layers: epicardium, myocardium, and endocardium.[0004]The sinoatrial node (often a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): C12N5/00C12N5/079A61K35/30A61K35/34C12N5/077
CPCA61K35/34A61K35/30C12N5/0618C12N5/0657C12N2510/00C12N2501/998C12N2506/08C12N2506/1384C12N2501/60A61P9/04A61P9/06
Inventor ALT, ECKHARDKARIMI, TAHEREH
Owner ALLIANCE OF CARDIOVASCULAR RESERS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products